CNS RESPONSE, INC.
Aliso Viejo, United States
- Website not added yet
- LinkedIn not added yet
- X not added yet
- Instagram not added yet
- Facebook not added yet
CNS RESPONSE, INC was founded by George Carpenter, Robert Follman, Paul Buck, Zachary McAdoo, Andrew Sassine, John Pappajohn, Geoffrey Harris, Robin Smith, Michal Votruba, Joseph Sherwood, Ian Pine Zwicker, Willis Lee, Masaharu Osato, Jane Pine Wood, Yutaka Niihara, Wei Peu Zen, Robert Dickey, Yasushi Nagasaki, Charles Stark, George Sekulich, Wei Peu (Derek) Zen, Ian Zwicker and Lim Seah, and is based in Aliso Viejo, United States.
Key facts
- Industry
- Pharmaceutical Preparations
- Legal form
- Incorporated in Delaware
- Listed
- OTC · EMMA
About
Pharmaceutical Preparations; formerly MYnd Analytics, Inc.; listed on OTC as EMMA; filing with the SEC since 2009
Founders
Executive Officer
1500 Founder Rating
Director
1500 Founder Rating
Executive Officer
1500 Founder Rating
Director
1500 Founder Rating
Director
1500 Founder Rating
Director
1500 Founder Rating
Director
1500 Founder Rating
Director
1500 Founder Rating
Director
1500 Founder Rating
Executive Officer
1500 Founder Rating
Director
1500 Founder Rating
Executive Officer, Director
1500 Founder Rating
Director
1500 Founder Rating
Director
1500 Founder Rating
Executive Officer, Director
1500 Founder Rating
Director
1500 Founder Rating
Director
1500 Founder Rating
Executive Officer
1500 Founder Rating
Executive Officer
1500 Founder Rating
Senior Vice President Global Commercialization
1500 Founder Rating
Director
1500 Founder Rating
Director
1500 Founder Rating
Director
1500 Founder Rating
In context
We hold 45 other pharmaceutical preparations companies. None has a closure on record yet. Of the 46 that report what they raised, the median is $55,000,208.
Counted across this directory, from founding and closing years in public records. Medians cover only companies whose closure is recorded; a company with no closure date may have quietly ceased without the record catching it.
Discussion
Log in to join the discussion and like comments.
Log In to Comment